IFT80 promotes early bone healing of tooth sockets through the activation of TAZ / RUNX2 pathway
Oral Diseases · 2024-10 · 30 (7) · 4558-4572
DOI: 10.1111/odi.14873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 29.01.2024. Verfasst von Ziwei Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Science of Stomatology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 1 Subunit, Tooth Socket, Mesenchymal Stem Cells, Osteogenesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Jiangsu Provincial Medical Innovation Center, Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Research Hospital Cultivation Unit, Natural Science Foundation of Jiangsu Province in China.
Abstract (Originalsprache)
Intraflagellar transport (IFT) proteins have been reported to regulate cell growth and differentiation as the essential functional component of primary cilia. The effects of IFT80 on early bone healing of extraction sockets have not been well studied. To investigate whether deletion of Ift80 in alveolar bone‐derived mesenchymal stem cells (aBMSCs) affected socket bone healing, we generated a mouse model of specific knockout of Ift80 in Prx1 mesenchymal lineage cells (Prx1 Cre ;IFT80 f/f ). Our results demonstrated that deletion of IFT80 in Prx1 lineage cells decreased the trabecular bone volume, ALP‐positive osteoblastic activity, TRAP‐positive osteoclastic activity, and OSX‐/COL I‐/OCN‐positive areas in tooth extraction sockets of Prx1 Cre ; IFT80 f/f mice compared with IFT80 f/f littermates. Furthermore, aBMSCs from Prx1 Cre ; IFT80 f/f mice showed significantly decreased osteogenic markers and downregulated migration and proliferation capacity. Importantly, the overexpression of TAZ recovered significantly the expressions of osteogenic markers and migration capacity of aBMSCs. Lastly, the local administration of lentivirus for TAZ enhanced the expression of RUNX2 and OSX and promoted early bone healing of extraction sockets from Prx1 Cre ; IFT80 f/f mice. Thus, IFT80 promotes osteogenesis and early bone healing of tooth sockets through the activation of TAZ/RUNX2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Science of Stomatology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.
- Department of Dental Implantology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.
- Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, China.
ORCID-Profile: Wen Sun
Förderung
- Jiangsu Provincial Medical Innovation Center
- Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Research Hospital Cultivation Unit
- Natural Science Foundation of Jiangsu Province in China
- National Natural Science Foundation of China
Zitieren
APA
Zhao, Z., Geng, Y., Ni, Q., Chen, Y., Cao, Y., Lu, Y., Wang, H., Wang, R., & Sun, W. (2024). IFT80 promotes early bone healing of tooth sockets through the activation of TAZ / RUNX2 pathway. Oral Diseases, 30(7), 4558-4572. https://doi.org/10.1111/odi.14873
Vancouver
Zhao Z, Geng Y, Ni Q, Chen Y, Cao Y, Lu Y, et al. IFT80 promotes early bone healing of tooth sockets through the activation of TAZ / RUNX2 pathway. Oral Diseases. 2024;30(7):4558-4572. doi:10.1111/odi.14873
BibTeX
@article{Zhao2024,
author = {Zhao, Ziwei and Geng, Ying and Ni, Qiaoqi and Chen, Yue and Cao, Yanan and Lu, Yahui and Wang, Hua and Wang, Ruixia and Sun, Wen},
title = {IFT80 promotes early bone healing of tooth sockets through the activation of TAZ / RUNX2 pathway},
journal = {Oral Diseases},
year = {2024},
volume = {30},
number = {7},
pages = {4558--4572},
doi = {10.1111/odi.14873}
}
EUVIMED